Citations for
1TCERG1
Specific interaction of the transcription elongation regulator TCERG1 with RNA polymerase II requires simultaneous phosphorylation at Ser2, Ser5, and Ser7 within the carboxyl-terminal domain repeat.
Liu J, Fan S, Lee CJ, Greenleaf AL, Zhou P.
J Biol Chem 288(15):10890-901. doi: 10.1074/jbc.M113.460238. Epub 2013 Feb 22. 2013
2BCL2L1, TCERG1
TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.
Montes M, Cloutier A, Sánchez-Hernández N, Michelle L, Lemieux B, Blanchette M, Hernández-Munain C, Chabot B, Suñé C.
Mol Cell Biol 32(4):751-62. doi: 10.1128/MCB.06255-11. Epub 2011 Dec 12. 2012
3TCERG1
The FF4 and FF5 domains of transcription elongation regulator 1 (TCERG1) target proteins to the periphery of speckles.
Sánchez-Hernández N, Ruiz L, Sánchez-Álvarez M, Montes M, Macias MJ, Hernández-Munain C, Suñé C.
J Biol Chem 287(21):17789-800. doi: 10.1074/jbc.M111.304782. Epub 2012 Mar 27. 2012
4TCERG1
Chemical synthesis of the third WW domain of TCERG 1 by native chemical ligation.
Fidan Z, Younis A, Schmieder P, Volkmer R.
J Pept Sci 17(9):644-9. doi: 10.1002/psc.1383. Epub 2011 Jun 10. 2011
5TCERG1, UBE2I
Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).
Sánchez-Alvarez M, Montes M, Sánchez-Hernández N, Hernández-Munain C, Suñé C.
J Biol Chem 285(20):15220-33. Epub 2010 Mar 9.PMID: 20215116 2010
6CEBPA, TCERG1
Nuclear redistribution of TCERG1 is required for its ability to inhibit the transcriptional and anti-proliferative activities of C/EBPalpha.
Banman SL, McFie PJ, Wilson HL, Roesler WJ.
J Cell Biochem 109(1):140-51. doi: 10.1002/jcb.22391. 2010
7TCERG1
Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing.
Pearson JL, Robinson TJ, Mu–oz MJ, Kornblihtt AR, Garcia-Blanco MA.
J Biol Chem 283(12):7949-61. Epub 2008 Jan 10. 2008
8TCERG1
Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
Andresen JM, Gay‡n J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA; US-Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS.
J Med Genet 44(1):44-50. Epub 2006 Oct 3. 2007
9TCERG1
Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions.
S‡nchez-Alvarez M, Goldstrohm AC, Garcia-Blanco MA, Su–Ž C.
Mol Cell Biol 26(13):4998-5014. 2006
10UBE2K, PACSIN1, ZDHHC17, TAF4, TRIP10, DLG4, SH3GL3, TCERG1, CTBP1, GAPDH
Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
Li SH, Li XJ.
Trends Genet 20(3):146-54. Review. 2004
11TCERG1
FF domains of CA150 bind transcription and splicing factors through multiple weak interactions.
Smith MJ, Kulkarni S, Pawson T.
Mol Cell Biol 24(21):9274-85. 2004
12TCERG1
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.
Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Neri C.
Proc Natl Acad Sci U S A 98(4):1811-6. 2001
13TCERG1
Expression analysis and mapping of the mouse and human transcriptional regulator CA150.
Bohne J, Cole SE, Sune C, Lindman BR, Ko VD, Vogt TF, Garcia-Blanco MA.
Mamm Genome 11(10):930-3. No abstract available. 2000
14TCERG1
CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription.
Sune C, Hayashi T, Liu Y, Lane WS, Young RA, Garcia-Blanco MA.
Mol Cell Biol 17(10):6029-39. 1997